[ad_1]
Cipla stands among the top 5 companies in the manufacturing sector and has the highest ESG score amongst peers in the pharmaceutical sector.
In 2021, Cipla also received recognition among the top 30 companies under the Indian Corporate Governance Scorecard 2021 and was amongst one of the most sustainable companies in the Dow Jones Sustainability Emerging Markets Index. Cipla also won the prestigious Frost & Sullivan and TERI’s Sustainability 4.0 Award 2021 as “Challenger in Mega Large Business Pharma Sector”.
“We are humbled and honored to receive this rank in CRISIL’s Sustainability report. It is a true testament to our relentless efforts and commitment toward sustainability which is embedded in our DNA at Cipla. Guided by our ethos of Caring for Life, we will continue to build sustainable solutions across markets for a healthier planet and society. It gives us great joy to be recognized for our efforts and we will continue to raise the bar going ahead,” commented Ms. Geena Malhotra, Global Chief Technology Officer who is spearheading Cipla’s ESG efforts.
The company’s Global ESG positioning C.A.R.E: Championing Climate Positivity, Accelerating Community Well-being, Raising the Bar on Governance, Enhancing Access & Affordability is aimed at developing a holistic sustainability road map for the future. By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship, and green chemistry.
Cipla is currently trading at Rs980.50 up by Rs10 or 1.03% from its previous closing of Rs970.50 on the BSE. The scrip opened at Rs 974.95 and has touched intraday high and low of Rs 986 and R s973 respectively.
[ad_2]
Source link